Brian Anderson

About the Author Brian Anderson


Analysts Offer Insights on Technology Companies: Splunk Inc (SPLK) and Veritone Inc (VERI)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Splunk Inc (SPLK) and Veritone …

Hilltop Holdings Inc (HTH) Receives a Hold from Stephens

In a report released today, Matt Olney from Stephens maintained a Hold rating on Hilltop Holdings Inc (HTH), with a price target of …

Wells Fargo Keeps Their Hold Rating on Colgate-Palmolive (CL)

Wells Fargo analyst Bonnie Herzog maintained a Hold rating on Colgate-Palmolive (CL) today and set a price target of $62. The company’s shares …

Oppenheimer Remains a Buy on Hms Holdings Corp (HMSY)

In a report released today, Mohan Naidu from Oppenheimer reiterated a Buy rating on Hms Holdings Corp (HMSY), with a price target of …

National Securities Corp Keeps Their Buy Rating on Digimarc Corp (DMRC)

In a report released today, Ilya Grozovsky from National Securities Corp maintained a Buy rating on Digimarc Corp (DMRC), with a price target …

Oppenheimer Sticks to Their Hold Rating for Globus Medical (GMED)

Oppenheimer analyst Steven Lichtman maintained a Hold rating on Globus Medical (GMED) today and set a price target of $56. The company’s shares …

Boston Beer (SAM) Receives a Rating Update from a Top Analyst

In a report released today, Vivien Azer from Cowen & Co. reiterated a Hold rating on Boston Beer (SAM), with a price target …

Cantor Fitzgerald Believes BioDelivery (BDSI) Still Has Room to Grow

Cantor Fitzgerald analyst Brandon Folkes reiterated a Buy rating on BioDelivery (BDSI) today and set a price target of $8. The company’s shares …

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Aerie Pharma (AERI), Dexcom (DXCM) and Regeneron (REGN)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aerie Pharma (AERI), Dexcom (DXCM) and Regeneron (REGN). …

Maxim Group Sticks to Their Hold Rating for Bluebird Bio (BLUE)

In a report released today, Jason McCarthy from Maxim Group maintained a Hold rating on Bluebird Bio (BLUE). The company’s shares closed yesterday …